Lyphe Group

Health & Beauty · Wellness & Self-Care

Lyphe Group is a UK-based medical cannabis supplier that prescribes and dispenses dried flower, oils, capsules and topical formulations through its online clinic and pharmacy network. Products are priced at a mid-to-premium level, typically £5-£12 per gram, with private consultations and next-day courier delivery nationwide. The company is the first fully integrated medical cannabis ecosystem in the UK, combining telemedicine clinics, a GPhC-registered pharmacy and in-house import & distribution under one roof. It owns the well-known “Medical Cannabis by Lyphe” formulary and has secured exclusive supply agreements for high-THC genetics such as NOIDECS and Adven, enabling same-week dispensing where competitors wait 4-6 weeks. Patients are UK adults with chronic pain, anxiety, PTSD or oncology-related symptoms who have failed two conventional treatments and can self-pay; they value legal, standardized cannabis over unregulated street product and want clinician oversight. The brand speaks to wellness-oriented, stigma-free consumers who prioritize discretion, legal compliance and repeatable cannabinoid profiles. Lyphe competes against other private cannabis clinics and pharmacies that rely on third-party importers; it differentiates through vertical integration that shortens supply lead times, reduces price volatility and allows real-time titration support via its patient portal.

Medical cannabis that arrives next week, not next month